Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-13

Clinical Trial Update: Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pre-mix insulin lispro for type 2 diabetes patients who consume a light breakfast; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pre-Mix Insulin Lispro (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2011-12-13